Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Phase II Open Label Study of PTK787/ZK222584 in Adults Patients With Refractory or Relapsed Diffuse Large Cell Lymphoma

NCT00511043 is registered in ClinicalTrials.gov with David Rizzieri, MD as lead sponsor.

NCT NCT00511043
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00511043 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Phase II Open Label Study of PTK787/ZK222584 in Adults Patients With Refractory or Relapsed Diffuse Large Cell Lymphoma
Lead sponsor
David Rizzieri, MD
Phase
Phase 2
Overall status
Terminated
Start date
November 30, 2005
Completion date
June 30, 2010
Enrollment
20 (actual)
Sites
3

Conditions

As the registry lists them; a condition with its own page is linked.

lymphoma, large-cell, diffuse